AstraZeneca has announced a global withdrawal of its COVID-19 vaccine, citing commercial reasons and the availability of updated vaccine options. The British pharmaceutical company also acknowledged rare side effects associated with the vaccine. Amidst this decision, AstraZeneca faces a hefty 100 million pound lawsuit over vaccine-related deaths and injuries. Despite the withdrawal, the company emphasizes the vaccine's significant role in saving lives. Experts anticipate the replacement of original strain vaccines with updated versions. The withdrawal will impact Covishield, the version of the vaccine produced by the Serum Institute of India. Watch the video to know more.

свернуть